Rimedion Company
Rimedion, Inc is a viral vector technology company founded in 2008 by Dr. Ken Cornetta of the Indiana University Vector Production Facility (IUVPF). The Indiana University School of medicine helped to found the company to absorb and manage commercial activity of the IUPVF. By taking over the commercial activity of IUVPF, Rimedion was able to make certification testing available and to provide production of clinical grade vectors for biotechnology companies and academic institutions. Rimedion has an exclusive license with the IUVPF to manage all outside requests thus utilizing IUVPFРІРђР©s scientific expertise while providing its customers with the ability to accelerate their production development path.
Headquarters:
Our passion, in all we do, is to improve the quality of individual health care through the development of gene therapy technologies.
Estimated Revenue:
Great Lakes, Midwestern US
Technology:
Others
Industry:
Gene Therapy